Terms: = Ovarian cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Staging
9 results:
1. [Expression and significance of immune checkpoint B7-homolog 4 in endometrial cancer].
Zong LJ; Xiang Y; Yu SN; Lu ZH; Chen J; Huang WH
Zhonghua Fu Chan Ke Za Zhi; 2022 Dec; 57(12):921-931. PubMed ID: 36562226
[No Abstract] [Full Text] [Related]
2. Protein expressions of AIB1, p53 and bcl-2 in epithelial ovarian cancer and their correlations with the clinical pathological features and prognosis.
Liang M; Zhao J
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5134-5139. PubMed ID: 30178833
[TBL] [Abstract] [Full Text] [Related]
3. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
[TBL] [Abstract] [Full Text] [Related]
4. Relationship between the expression of the extracellular matrix genes SPARC, SPP1, FN1, ITGA5 and ITGAV and clinicopathological parameters of tumor progression and colorectal cancer dissemination.
Viana Lde S; Affonso RJ; Silva SR; Denadai MV; Matos D; Salinas de Souza C; Waisberg J
Oncology; 2013; 84(2):81-91. PubMed ID: 23128103
[TBL] [Abstract] [Full Text] [Related]
5. P53 and bcl-2 as prognostic markers in endometrial carcinoma.
Appel ML; Edelweiss MI; Fleck J; Rivero LF; Rivoire WA; Mônego HI; Dos Reis R
Pathol Oncol Res; 2008 Mar; 14(1):23-30. PubMed ID: 18398703
[TBL] [Abstract] [Full Text] [Related]
6. Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent disease.
Williams J; Lucas PC; Griffith KA; Choi M; Fogoros S; Hu YY; Liu JR
Gynecol Oncol; 2005 Feb; 96(2):287-95. PubMed ID: 15661210
[TBL] [Abstract] [Full Text] [Related]
7. Clinical and biological characteristics of clear cell carcinomas of the ovary in FIGO stages I-II.
Skírnisdóttir I; Seidal T; Karlsson MG; Sorbe B
Int J Oncol; 2005 Jan; 26(1):177-83. PubMed ID: 15586238
[TBL] [Abstract] [Full Text] [Related]
8. bcl-2 expression in a primary leiomyosarcoma of the ovary: a case report.
Bodner K; Bodner-Adler B; Czerwenka K; Hudelist G; Kimberger O; Leodolter S; Mayerhofer K
Wien Klin Wochenschr; 2003 Mar; 115(5-6):191-5. PubMed ID: 12741081
[TBL] [Abstract] [Full Text] [Related]
9. Immunohistochemical evaluation is not prognostic for recurrence in fully staged high-risk endometrial cancer.
Fanning J; Brown S; Phibbs G; Kramer T; Zaher A
Int J Gynecol Cancer; 2002; 12(3):286-9. PubMed ID: 12060450
[TBL] [Abstract] [Full Text] [Related]